Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mapracorat Adrenal Suppression in Japanese Adults with Atopic Dermatitis
NCT01407510Phase 2Completed
- Sponsor
- Bayer
- Start
- May 2011
- Primary completion
- Sep 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of mapracorat in atopic dermatitis (AD), sponsored by Bayer. Started May 2011; status: completed.
02
Drugs
mapracorat
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT01407510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01407510.